Real-Life Use of Subcutaneous Biologicals and JAK Inhibitors in IBD Maintenance Therapy: Treatment Continuation, Switching Patterns, and Concomitant Medications

Clinical and Experimental Gastroenterology · Published 2026-01-01 · DOI 10.2147/ceg.s576384

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.2147/ceg.s576384

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles